Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Caris Life Sciences Inc.

    NASDAQ: CAI · Real-Time Price · USD
    36.14
    -0.79 (-2.14%)
    At close: Aug 20, 2025, 10:08 AM

    Caris Life Sciences Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q3 2021 Q2 2021 Q1 2021
    Period Ending Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
    Revenue
    		 331.64M 309.87M 299.9M
    Cost of Revenue
    		 155.31M 139M 125.02M
    Gross Profit
    		 176.33M 170.87M 174.88M
    Operating Income
    		 202.11M 171.22M 153.39M
    Interest Income
    		 n/a n/a n/a
    Pretax Income
    		 182.39M 145.88M 123.14M
    Net Income
    		 139.08M 103.37M 64.8M
    Selling & General & Admin
    		 34.92M 35.7M 39.4M
    Research & Development
    		 n/a n/a n/a
    Other Expenses
    		 n/a n/a n/a
    Operating Expenses
    		 34.92M 35.7M 39.4M
    Interest Expense
    		 29.25M 45.88M 52.36M
    Selling & Marketing Expenses
    		 -1.15M 5.54M 12.01M
    Cost & Expenses
    		 190.24M 174.71M 164.42M
    Income Tax Expense
    		 10.43M 8.1M 7.36M
    Shares Outstanding (Basic)
    		 17.34M 17.28M 17.27M
    Shares Outstanding (Diluted)
    		 17.53M 17.48M 17.52M
    EPS (Basic)
    		 8.02 5.95 3.71
    EPS (Diluted)
    		 7.92 5.87 3.66
    EBITDA
    		 293.62M 269.94M 236.22M
    EBIT
    		 156.81M 191.75M 175.5M
    Depreciation & Amortization
    		 114.85M 112.59M 111.7M

    Add to Watchlist